Market Tracker

05/29 8:56am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

2.51
Delayed Data
As of May 26
 +0.15 / +6.36%
Today’s Change
0.49
Today|||52-Week Range
3.68
+156.17%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close2.36
Today’s open2.36
Day’s range2.32 - 2.55
Volume194,577
Average volume (3 months)573,157
Market cap$87.0M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+13.64%
Earnings growth (this year)+34.87%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book27.06

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.05-1.25%
VRMLVermillion Inc+0.09+5.00%
TRIBTrinity Biotech PLC+0.14+2.59%
TRILTrillium Therapeutic...-0.45-8.26%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$21.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts